Search Results - "Gouget, Hélène"
-
1
UPLC–MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma
Published in Journal of pharmaceutical and biomedical analysis (20-03-2020)“…•New quantification method for 13 antiretroviral drugs with most recent bictegravir and two booster cobicistat and ritonavir.•Sensitive and rapid ultra-high…”
Get full text
Journal Article -
2
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells
Published in Nature communications (11-01-2024)“…HIV remission can be achieved in some people, called post-treatment HIV controllers, after antiretroviral treatment discontinuation. Treatment initiation close…”
Get full text
Journal Article -
3
Pharmacokinetics and tissue distribution of tenofovir, emtricitabine and dolutegravir in mice
Published in Journal of antimicrobial chemotherapy (31-03-2022)“…Abstract Background Studies of antiretroviral drug (ARV) tissue distribution in preclinical models, such as mice, are key to understanding viral persistence…”
Get full text
Journal Article -
4
Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates
Published in Journal of antimicrobial chemotherapy (03-09-2024)“…Abstract Background One major barrier to HIV cure is the persistence of virus, possibly linked to an insufficient antiretroviral drug (ARV) distribution into…”
Get full text
Journal Article -
5
Characteristics of Dolutegravir and Bictegravir Plasma Protein Binding: a First Approach for the Study of Pharmacologic Sanctuaries
Published in Antimicrobial agents and chemotherapy (20-10-2020)“…This study aimed to characterize dolutegravir (DTG) and bictegravir (BIC) binding. They had a preferential binding to human serum albumin (HSA) with two…”
Get full text
Journal Article -
6
Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment
Published in Journal of antimicrobial chemotherapy (12-11-2021)“…Abstract Objectives The penetration of antiretroviral drugs into deep compartments, such as the CNS, is a crucial component of strategies towards an HIV cure…”
Get full text
Journal Article -
7
Preclinical development and pharmacokinetic assessment in macaques of a multipurpose long-acting injectable suspension containing medroxyprogesterone acetate for contraception and rilpivirine for HIV prevention
Published in Journal of drug delivery science and technology (01-08-2023)“…Depot injections comprising aqueous drug suspensions are widely marketed for long-acting administration of contraceptive progestins and antipsychotics. In…”
Get full text
Journal Article -
8
Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates
Published in Pharmaceutics (25-10-2022)“…The development of animal models undergoing long-term antiretroviral treatment (ART) makes it possible to understand a number of immunological, virological,…”
Get full text
Journal Article